Alejandro Sánchez-Chardi

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Pharmaceutics

Cancers

International journal of molecular sciences

Oncoimmunology

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universitat de Barcelona

Spain

PHD :: Zoology

Publications

François Chauvigné, Júlia Castro-Arnau, Noelia López-Fortún, Alejandro Sánchez-Chardi, Michael Rützler, Giuseppe Calamita, Roderick Nigel Finn, Joan Cerdà
Aquaporin-3a Dysfunction Impairs Osmoadaptation in Post-Activated Marine Fish Spermatozoa. International journal of molecular sciences 25 (17) (2024)
Naroa Serna, Aïda Falgàs, Annabel García-León, Ugutz Unzueta, Yáiza Núñez, Alejandro Sánchez-Chardi, Carlos Martínez-Torró, Ramón Mangues, Esther Vazquez, Isolda Casanova, Antonio Villaverde
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials. Pharmaceutics 14 (1) (2022)
Julieta María Sánchez, José Vicente Carratalá, Naroa Serna, Ugutz Unzueta, Verónica Nolan, Alejandro Sánchez-Chardi, Eric Voltà-Durán, Hèctor López-Laguna, Neus Ferrer-Miralles, Antonio Villaverde, Esther Vazquez
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies. Pharmaceutics 14 (3) (2022)
Sandra Guallar-Garrido, Víctor Campo-Pérez, Miriam Pérez-Trujillo, Cecilia Cabrera, Jordi Senserrich, Alejandro Sánchez-Chardi, Rosa Maria Rabanal, Elisabet Gómez-Mora, Estela Noguera-Ortega, Marina Luquin, Esther Julián
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment. Oncoimmunology 11 (1) (2022)
Víctor Campo-Pérez, Sandra Guallar-Garrido, Marina Luquin, Alejandro Sánchez-Chardi, Esther Julián
The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium as a Versatile Cell Factory for Lipid Compounds of Therapeutic Interest. International journal of molecular sciences 23 (21) (2022)
Olivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, Aïda Falgàs, Alejandro Sánchez-Chardi, Naroa Serna, Eloi Parladé, Ugutz Unzueta, Mònica Roldán, Eric Voltà-Durán, Isolda Casanova, Antonio Villaverde, Ramón Mangues, Esther Vazquez
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers. Cancers 13 (12) (2021)
Laura Martínez-Escardó, Montse Alemany, María Sánchez-Osuna, Alejandro Sánchez-Chardi, Meritxell Roig-Martínez, Salvio Suárez-García, Daniel Ruiz-Molina, Noemí Vidal, Gerard Plans, Carles Majos, Judit Ribas, María Antonia Baltrons, José-Ramón Bayascas, Carlos Barcia, Jordi Bruna, Víctor J Yuste
Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells. Cancers 13 (21) (2021)
Jose V Carratalá, Eric Brouillette, Naroa Serna, Alejandro Sánchez-Chardi, Julieta M Sánchez, Antonio Villaverde, Anna Arís, Elena Garcia-Fruitós, Neus Ferrer-Miralles, François Malouin
In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics. Pharmaceutics 12 (12) (2020)
Sandra Guallar-Garrido, Víctor Campo-Pérez, Alejandro Sánchez-Chardi, Marina Luquin, Esther Julián
Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect. Microorganisms 8 (5) (2020)

Alejandro Sánchez-Chardi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Sánchez-Chardi